Analyze Diet
Veterinary anaesthesia and analgesia2013; 40(4); 375-381; doi: 10.1111/vaa.12009

Influence of detomidine and xylazine on spleen dimensions and on splenic response to epinephrine infusion in healthy adult horses.

Abstract: To compare the changes in splenic length and thickness and in packed cell volume (PCV) following detomidine or xylazine administration and subsequent epinephrine infusion. Objective: Spleen relaxation occurs following xylazine or detomidine administration and interferes with subsequent splenic contractile response to epinephrine. Methods: Randomized non-blinded crossover experimental study. Methods: 6 healthy adult mares. Methods: The mares received an intravenous (IV) epinephrine infusion (1 μg kg(-1 ) minute(-1) over 5 minutes) one hour after IV administration of detomidine (0.01 mg kg(-1) ), xylazine (0.5 mg kg(-1) ) or no drug (control), with a withdrawal period of at least 7 days between experiments. The splenic length measured in two different axes, the splenic thickness, and the PCV were measured prior to sedation (T0), 30 minutes later, and at 5-minute intervals from the start of the epinephrine infusion (T1) until T1 + 40 minutes. Changes from base-line and between treatments were compared using a two-way anova for repeated measures. Significance was set at p < 0.05. Results: Splenic length was significantly increased and PCV was significantly decreased after detomidine administration compared to baseline. Epinephrine infusion resulted in a significant decrease in splenic length and thickness, and a significant increase in PCV, irrespective of prior treatment with detomidine or xylazine. Conclusions: Detomidine administration was followed by a sonographically detectable increase of splenic length. Neither detomidine nor xylazine interfered with the ability of the spleen to contract following subsequent administration of an epinephrine infusion given one hour later. Conclusions: Previous sedation with alpha-2 agonists does not preclude the efficiency of epinephrine as a medical treatment of left dorsal displacement of the large colon, but further investigations are required with other drug doses and different time intervals between administrations.
Publication Date: 2013-02-12 PubMed ID: 23402588DOI: 10.1111/vaa.12009Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the effects of the drugs detomidine and xylazine on the spleen of adult horses, and their interaction with a following infusion of epinephrine. The study finds neither detomidine nor xylazine hinder the spleen’s ability to contract after an epinephrine infusion, indicating the efficiency of epinephrine in treating large colon displacement isn’t impeded by prior treatment with these drugs, although further study is necessary.

Methodology

  • The research used a randomized non-blinded crossover experiment, involving six healthy adult mares.
  • The mares were given an intravenous infusion of epinephrine at a rate of 1 μg kg(-1) minute(-1) over 5 minutes. This was done one hour after they were given an intravenous dose of either detomidine (0.01 mg kg(-1)), xylazine (0.5 mg kg(-1)), or no drug at all (control group).
  • There was a withdrawal period of at least 7 days between each experiment.
  • The splenic length and thickness, as well as packed cell volume (PCV), were measured prior to sedation, 30 minutes later, and at 5-minute intervals from the start of the epinephrine infusion until 40 minutes later.
  • Changes from the baseline and comparison of treatment effects were determined through the use of two-way ANOVA for repeated measures. Any change with a p-value of less than 0.05 was considered significant.

Results

  • Following detomidine administration, there was a noticeable increase in spleen length and a decrease in PCV compared to baseline readings.
  • The epinephrine infusion further resulted in a significant reduction in spleen length and thickness and an increase in PCV. These changes were irrespective of whether the horse had been pre-treated with detomidine or xylazine.

Conclusions

  • Upon administering detomidine, there is a visible increase in spleen length as viewed through sonography.
  • The study revealed that neither detomidine nor xylazine interfered with the spleen’s ability to contract subsequent to the administration of an epinephrine infusion.
  • However, the study suggests the need for further investigations, particularly focusing on the use of different drug doses and varying time intervals between administrations, to more thoroughly understand the interaction between these drugs in the application of medical treatment for left dorsal displacement of the large colon in horses.

Cite This Article

APA
Deniau V, Depecker M, Bizon-Mercier C, Couroucé-Malblanc A. (2013). Influence of detomidine and xylazine on spleen dimensions and on splenic response to epinephrine infusion in healthy adult horses. Vet Anaesth Analg, 40(4), 375-381. https://doi.org/10.1111/vaa.12009

Publication

ISSN: 1467-2995
NlmUniqueID: 100956422
Country: United States
Language: English
Volume: 40
Issue: 4
Pages: 375-381

Researcher Affiliations

Deniau, Valérie
  • LUNAM Université, ONIRIS, UPSP 5304 Laboratoire de Physiopathologie animale et de Pharmacologie fonctionnelle, Atlanpôle - La Chantrerie, Nantes, France. vdeniau@hotmail.com
Depecker, Marianne
    Bizon-Mercier, Céline
      Couroucé-Malblanc, Anne

        MeSH Terms

        • Animals
        • Cross-Over Studies
        • Epinephrine / pharmacology
        • Female
        • Horses
        • Hypnotics and Sedatives / pharmacology
        • Imidazoles / pharmacology
        • Spleen / drug effects
        • Spleen / physiology
        • Xylazine / pharmacology